Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies

Technologies required to generate induced pluripotent stem cells (iPSC) were first described 15 years ago, providing a strong impetus to the field of regenerative medicine. In parallel, immunotherapy has finally emerged as a clinically meaningful modality of cancer therapy. In particular, impressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazza, Roberta, Maher, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666432/
https://www.ncbi.nlm.nih.gov/pubmed/34897554
http://dx.doi.org/10.1007/s00005-021-00640-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666432/
https://www.ncbi.nlm.nih.gov/pubmed/34897554
http://dx.doi.org/10.1007/s00005-021-00640-7

Ejemplares similares